BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20629842)

  • 1. BerEP4-negative basal cell carcinoma on the palm: case report and review of the literature.
    Mleczko A; Franke I; Pokrywka A; Gollnick H; Leverkus M
    J Dtsch Dermatol Ges; 2011 Feb; 9(2):140-3. PubMed ID: 20629842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
    Yu L; Galan A; McNiff JM
    J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers.
    Sellheyer K
    Br J Dermatol; 2011 Apr; 164(4):696-711. PubMed ID: 21128907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
    Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
    Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers.
    Sellheyer K; Nelson P; Kutzner H; Patel RM
    J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
    Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
    Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 and CD10 expression in the differential diagnosis of trichoblastoma, basal cell carcinoma, and basal cell carcinoma with follicular differentiation.
    Córdoba A; Guerrero D; Larrinaga B; Iglesias ME; Arrechea MA; Yanguas JI
    Int J Dermatol; 2009 Jul; 48(7):713-7. PubMed ID: 19570076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinoma with matrical differentiation in a transplant patient: a case report and review of the literature.
    Ali F; Brown A; Gottwald L; Thomas J
    J Cutan Pathol; 2005 Jul; 32(6):445-8. PubMed ID: 15953381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD10 expression in trichoepithelioma and basal cell carcinoma.
    Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C
    J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
    Kanoh M; Amoh Y; Sato Y; Katsuoka K
    Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHLDA1 (TDAG51) is a follicular stem cell marker and differentiates between morphoeic basal cell carcinoma and desmoplastic trichoepithelioma.
    Sellheyer K; Krahl D
    Br J Dermatol; 2011 Jan; 164(1):141-7. PubMed ID: 20846311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous carcinosarcoma: adnexal vs. epidermal types define high- and low-risk tumors. Results of a meta-analysis.
    Tran TA; Muller S; Chaudahri PJ; Carlson JA
    J Cutan Pathol; 2005 Jan; 32(1):2-11. PubMed ID: 15660649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of stem cell markers nestin and cytokeratin 15 and 19 in cutaneous malignancies.
    Abbas O; Bhawan J
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):311-6. PubMed ID: 20629844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
    Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
    Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal cell carcinoma of the buccal mucosa in a patient with nevoid basal cell carcinoma syndrome.
    Shumway BS; Kalmar JR; Allen CM; Rawal YB
    Int J Surg Pathol; 2011 Jun; 19(3):348-54. PubMed ID: 19124449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric basal cell carcinoma: case reports and literature review.
    Efron PA; Chen MK; Glavin FL; Kays DW; Beierle EA
    J Pediatr Surg; 2008 Dec; 43(12):2277-80. PubMed ID: 19040953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokeratin profile in basal cell carcinoma.
    Alessi E; Venegoni L; Fanoni D; Berti E
    Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
    Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor of follicular infundibulum is Basal cell carcinoma.
    Weyers W; Hörster S; Diaz-Cascajo C
    Am J Dermatopathol; 2009 Oct; 31(7):634-41. PubMed ID: 19652582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.